Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amrubicin + Lenalidomide + Dexamethasone in R/R Multiple Myeloma
NCT01355705Phase 2Completed
- Start
- Aug 2011
- Primary completion
- Jul 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of amrubicin in multiple myeloma (MM). Started Aug 2011; status: completed.
02
Drugs
amrubicin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01355705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355705.